GlassScriptPhysician profile
Lindsay Howe
NPI 1982135760
$1,070.53
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $76.87 · 2022: $96.54 · 2023: $675 · 2024: $97.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $389.24 | 2021-2023 | Da Vinci Surgical System |
| Allergan, INC. | $124.80 | 2019 | |
| Abbvie INC. | $110.28 | 2023 | |
| Kci USA, INC. | $101.37 | 2022-2023 | V.A.C. Veraflo, Prevena, Fistula Solution |
| Astrazeneca Pharmaceuticals LP | $81.37 | 2022-2023 | |
| Csl Behring | $43.95 | 2022-2023 | Kcentra |
| Medtronic, INC. | $36.86 | 2023 | Signia |
| Zimmer Biomet Holdings, INC. | $28.32 | 2024 | Advantagerib |
| Edwards Lifesciences Corporation | $26.89 | 2024 | Hemosphere |
| Kerecis Limited | $26.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Urgo Medical North America, LLC | $22.83 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Avanos Medical | $21.87 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.59 | 2022 | |
| Ethicon US, LLC | $19.45 | 2024 | Echelon; Endopath |
| Smith+Nephew, INC. | $17.68 | 2023 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.